We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: a multicenter phase II trial.
- Authors
Small, William, Jr; Berlin, Jordan; Freedman, Gary M; Lawrence, Theodore; Talamonti, Mark S; Mulcahy, Mary F; Chakravarthy, A Bapsi; Konski, Andre A; Zalupski, Mark M; Philip, Philip A; Kinsella, Timothy J; Merchant, Nipun B; Hoffman, John P; Benson, Al B; Nicol, Steven; Xu, Rong M; Gill, John F; McGinn, Cornelius J
- Abstract
Gemcitabine is effective in the treatment of pancreatic cancer and is a potent radiosensitizer. This study assessed safety and efficacy of full-dose gemcitabine administered before and during concurrent three-dimensional conformal radiation (3D-CRT) in patients with nonmetastatic pancreatic cancer.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Vol 26, Issue 6, p942
- ISSN
1527-7755
- Publication type
Journal Article
- DOI
10.1200/JCO.2007.13.9014